{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["16(2)"],"submitter":["Abdalla TSA"],"pubmed_abstract":["<h4>Background</h4>Patient selection for lymphadenectomy remains a controversial aspect in the treatment of pancreatic neuroendocrine tumors (pNETs), given the growing importance of parenchyma-sparing resections and minimally invasive procedures.<h4>Methods</h4>This population-based analysis was derived from the German Cancer Registry Group during the period from 2000 to 2021. Patients with upfront resected non-functional non-metastatic pNETs were included.<h4>Results</h4>Out of 5520 patients with pNET, 1006 patients met the inclusion criteria. Fifty-three percent of the patients were male. The median age was 64 ± 17 years. G1, G2, and G3 pNETs were found in 57%, 37%, and 7% of the patients, respectively. Lymph node metastasis (LNM) was present in 253 (24%) of all patients. LNM was an inde"],"journal":["Cancers"],"pagination":["440"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10814740"],"repository":["biostudies-literature"],"pubmed_title":["When Should Lymphadenectomy Be Performed in Non-Metastatic Pancreatic Neuroendocrine Tumors? A Population-Based Analysis of the German Clinical Cancer Registry Group."],"pmcid":["PMC10814740"],"pubmed_authors":["Litkevych S","Deichmann S","Bronsert P","Wellner UF","Abdalla TSA","Braun R","Zeissig SR","Keck T","Bolm L","Gebauer J","Kleihues van Tol K","Klinkhammer-Schalke M","Hummel R","Honselmann KC"],"additional_accession":[]},"is_claimable":false,"name":"When Should Lymphadenectomy Be Performed in Non-Metastatic Pancreatic Neuroendocrine Tumors? A Population-Based Analysis of the German Clinical Cancer Registry Group.","description":"<h4>Background</h4>Patient selection for lymphadenectomy remains a controversial aspect in the treatment of pancreatic neuroendocrine tumors (pNETs), given the growing importance of parenchyma-sparing resections and minimally invasive procedures.<h4>Methods</h4>This population-based analysis was derived from the German Cancer Registry Group during the period from 2000 to 2021. Patients with upfront resected non-functional non-metastatic pNETs were included.<h4>Results</h4>Out of 5520 patients with pNET, 1006 patients met the inclusion criteria. Fifty-three percent of the patients were male. The median age was 64 ± 17 years. G1, G2, and G3 pNETs were found in 57%, 37%, and 7% of the patients, respectively. Lymph node metastasis (LNM) was present in 253 (24%) of all patients. LNM was an inde","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Jan","modification":"2025-04-21T15:53:51.014Z","creation":"2025-04-21T15:53:51.014Z"},"accession":"S-EPMC10814740","cross_references":{"pubmed":["38275882"],"doi":["10.3390/cancers16020440"]}}